Squarepoint’s Vivani Medical VANI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-5,568
Closed -$53K 3547
2021
Q3
$53K Buy
+5,568
New +$62.7K ﹤0.01% 2766
2021
Q1
Sell
-5,227
Closed -$29K 3658
2020
Q4
$29K Buy
+5,227
New +$18.5K ﹤0.01% 2829
2017
Q4
Sell
-1,742
Closed -$50K 2356
2017
Q3
$50K Buy
+1,742
New +$48.7K ﹤0.01% 1558
2017
Q1
Sell
-665
Closed -$31K 1928
2016
Q4
$31K Buy
+665
New +$38K ﹤0.01% 1717
2015
Q2
Sell
-795
Closed -$244K 616
2015
Q1
$244K Buy
+795
New +$221K 0.09% 335

Other funds holding VANI

Squarepoint's VANI Position: Q4 2021 in Review

Squarepoint sold out of Vivani Medical (VANI) in Q4 2021, closing a stake of 5,568 shares — an estimated $53K sold.

Squarepoint first reported a position in VANI in Q1 2015 and held it in 5 quarters. The position peaked at $244K in Q1 2015. 30 funds tracked by Wall St. Rank hold VANI as of Q4 2021.

  • Squarepoint reported no remaining Vivani Medical position as of Q4 2021 after selling out during the quarter.
  • Squarepoint sold 5,568 Vivani Medical shares in Q4 2021, an estimated $53K.
  • Squarepoint first reported a position in Vivani Medical in Q1 2015 and held it in 5 quarters.
  • Squarepoint's Vivani Medical position peaked at $244K in Q1 2015.
  • 30 funds tracked by Wall St. Rank held Vivani Medical as of Q4 2021.

Based on Squarepoint's 13F filing for Q4 2021, filed 14 Feb 2022.